
The FDA has approved the first-ever vaccine for RSV
GSK’s shot, for those 60 and over, can protect against severe respiratory syncytial virus. Other vaccines, including to protect newborns, are in the works.
GSK’s shot, for those 60 and over, can protect against severe respiratory syncytial virus. Other vaccines, including to protect newborns, are in the works.